Institutional investors hold a majority ownership of CELG through the 83.78% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2013, these large investors purchased a net $152.2 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JENNISON ASSOCIATES LLC Bought 1.5 Million shares of Celgene Corp
JPMORGAN INVESTMENT MANAGEMENT, ... Bought 1.3 Million shares of Celgene Corp
WINSLOW CAPITAL MANAGEMENT LLC Bought 1.2 Million shares of Celgene Corp